Tonix Pharmaceuticals Holding (TNXP) Net Margin (2022 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted Net Margin of 299.41% for Q2 2026, up 48.77% on a QoQ basis from 584.38% in Q1 2026, and up 111561.0% year-over-year from N/an in Q2 2025.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) Net Margin (2022 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding has reported Net Margin for 5 years, with the latest figure at 299.41% in Q2 2026.
- On a quarterly basis, Net Margin rose 111561.0% year-over-year to 299.41% in Q2 2026; TTM through Jun 2026 was 548.64%, a 27957.0% increase from a year earlier, with the FY2025 full-year figure at 946.22%, up 34203.0% from the prior year.
- Net Margin was 299.41% for Q2 2026 at Tonix Pharmaceuticals Holding, up from 584.38% in the prior quarter.
- The five-year high for Net Margin was 299.41% in Q2 2026, with the low at 3567.75% in Q2 2024.
- Average Net Margin over 5 years is 930.98%, with a median of 723.0% recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Net Margin sank 276764 bps in 2024, then soared 215274 bps in 2025.
- Over 5 years, Net Margin stood at 797.28% in 2022, then advanced by 9 bps to 723.0% in 2023, then retreated by 18 bps to 856.24% in 2024, then fell by 2 bps to 870.32% in 2025, then soared by 66 bps to 299.41% in 2026.
- The last three Net Margin figures came in at 299.41% (Q2 2026), 584.38% (Q1 2026), and 870.32% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -8.05% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 22.65% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -1.58% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 2.96% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 13.90% |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 34.98% |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn | -299.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -299.41% |
| Mar 31, 2026 | -584.38% |
| Dec 31, 2025 | -870.32% |
| Sep 30, 2025 | -972.95% |
| Jun 30, 2025 | -1,415.02% |
| Mar 31, 2025 | -692.84% |
| Dec 31, 2024 | -856.24% |
| Sep 30, 2024 | -503.65% |
| Jun 30, 2024 | -3,567.75% |
| Mar 31, 2024 | -601.89% |
| Dec 31, 2023 | -723.00% |
| Sep 30, 2023 | -701.30% |
| Jun 30, 2023 | -800.11% |
| Sep 30, 2022 | -797.28% |
| Jun 30, 2022 | -578.56% |